冷泉港亞洲2013會議：疫苗設(shè)計
Vaccine Design
疫苗設(shè)計
2013年6月3-7日 | 蘇州獨墅湖會議酒店
|
科學(xué)組委會成員: Michael Good, Griffith University, AUSTRALIA Yiming Shao, Chinese Center for Disease Control and Prevention, CHINA Linqi Zhang, Tsinghua University, CHINA |
主題演講嘉賓:
Dennis Burton, The Scripps Research Institute, USA
HIV vaccine targets identified by broadly neutralizing antibodies
David Ho, Aaron Diamond AIDS Res Center, USA
Potent Neutralizing Monoclonal Antibodies as Passive Vaccines against HIV
Dennis Burton, The Scripps Research Institute, USA
HIV vaccine targets identified by broadly neutralizing antibodies
David Ho, Aaron Diamond AIDS Res Center, USA
Potent Neutralizing Monoclonal Antibodies as Passive Vaccines against HIV
特邀演講嘉賓:
Gabrielle Belz, Walter and Eliza Hall Institute of Medical Research, Australia
Sentinal protection of mucosal tissues - insights to development, lineage relationships and protection by innate lymphoid cells
Michael Good, Griffith University, AUSTRALIA
Strain and species-transcending immunity induced by exposure to low doses of blood stage malaria parasites - a new paradigm for vaccine development
Ken Ishii, National Institute of Biomedical Innovation(NIBIO), Immunology Frontier Research Center (IFREC), Osaka University, Japan
Biomarkers and molecular mechanisms of vaccine adjuvant
Rajiv Khanna, Queensland Institute of Medical Research, Australia
Challenges in designing prophylactic vaccines against human herpesviruses
David Klatzmann, UMR 7211 UPMC/CNRS, Pierre & Marie Curie University, France
Towards preventive and therapeutic HCV vaccines: induction of broadly neutralizing antibodies using a novel VLP-based vaccine platform
Mi-Na Kweon, International Vaccine Institute, Korea
Acute epithelial death plays a role in intrinsic defense against enteric bacteria
Thomas Lehner, Kings College London, UK
The protective mechanism of innate ApoBECgG deaminase and adaptive activation induced deaminase (AID) in HLA-HIV immunised macaqires
Larry (Huaxin) Liao, Duke University Medical Center, USA
The Path Forward For HIV Vaccine Development: Regulation of Protective Antibodies
Shan Lu, University of Massachusetts Medical Center, USA
DNA vaccination at the cross road of acquired and innate immunities
M. Juliana McElrath, Fred Hutchinson Cancer Research Center, USA
HIV Vaccine-Induced Immunity
James Mullins, University of Washington, USA
Alteration of the immundominance hierarchy of HIV-1 Gag induced by a DNA vaccine expressing conserved elements of p24gag in macaques
David Pascual, Montana State University, USA
Mucosal Vaccination Protects Against Pulmonary and Systemic Brucellosis
Ruth Ruprecht, Dana-Farber Cancer Institute, USA
Humoral Correlates of Protection against Mucosal Simian-human Immunodeficiency Virus Transmission
Yiming Shao, Chinese Center for Disease Control and Prevention, China
The past achievement, current challenges and future opportunities for vaccine research in China
Zhong Su, Guangzhou Institutes of Biomedicine and Health, China
Development of a transgenic whole pathogen blood-stage malaria vaccine
Richard Wyatt, The Scripps Research Institute, USA
HIV-1 envelope glycoprotein immunogen/vaccine design and analysis
Cassian Yee, University of Washington, USA
T Cell Therapy and Cancer Vaccines: Two sides. Same Coin
Linqi Zhang, Tsinghua University, China
Antibody profiling, epitope mapping and vaccine design based on yeast surface display system
Tongqing Zhou, Vaccine Research Center, NIAID/NIH, USA
From antibody to antibodyome: Seeking the coordinates for an effective HIV-1 vaccine
Jiang Zhu, NIH/NIAID, USA
Combining Deep Sequencing and Protein Design - A Systematic Approach to Vaccine Development
Gabrielle Belz, Walter and Eliza Hall Institute of Medical Research, Australia
Sentinal protection of mucosal tissues - insights to development, lineage relationships and protection by innate lymphoid cells
Michael Good, Griffith University, AUSTRALIA
Strain and species-transcending immunity induced by exposure to low doses of blood stage malaria parasites - a new paradigm for vaccine development
Ken Ishii, National Institute of Biomedical Innovation(NIBIO), Immunology Frontier Research Center (IFREC), Osaka University, Japan
Biomarkers and molecular mechanisms of vaccine adjuvant
Rajiv Khanna, Queensland Institute of Medical Research, Australia
Challenges in designing prophylactic vaccines against human herpesviruses
David Klatzmann, UMR 7211 UPMC/CNRS, Pierre & Marie Curie University, France
Towards preventive and therapeutic HCV vaccines: induction of broadly neutralizing antibodies using a novel VLP-based vaccine platform
Mi-Na Kweon, International Vaccine Institute, Korea
Acute epithelial death plays a role in intrinsic defense against enteric bacteria
Thomas Lehner, Kings College London, UK
The protective mechanism of innate ApoBECgG deaminase and adaptive activation induced deaminase (AID) in HLA-HIV immunised macaqires
Larry (Huaxin) Liao, Duke University Medical Center, USA
The Path Forward For HIV Vaccine Development: Regulation of Protective Antibodies
Shan Lu, University of Massachusetts Medical Center, USA
DNA vaccination at the cross road of acquired and innate immunities
M. Juliana McElrath, Fred Hutchinson Cancer Research Center, USA
HIV Vaccine-Induced Immunity
James Mullins, University of Washington, USA
Alteration of the immundominance hierarchy of HIV-1 Gag induced by a DNA vaccine expressing conserved elements of p24gag in macaques
David Pascual, Montana State University, USA
Mucosal Vaccination Protects Against Pulmonary and Systemic Brucellosis
Ruth Ruprecht, Dana-Farber Cancer Institute, USA
Humoral Correlates of Protection against Mucosal Simian-human Immunodeficiency Virus Transmission
Yiming Shao, Chinese Center for Disease Control and Prevention, China
The past achievement, current challenges and future opportunities for vaccine research in China
Zhong Su, Guangzhou Institutes of Biomedicine and Health, China
Development of a transgenic whole pathogen blood-stage malaria vaccine
Richard Wyatt, The Scripps Research Institute, USA
HIV-1 envelope glycoprotein immunogen/vaccine design and analysis
Cassian Yee, University of Washington, USA
T Cell Therapy and Cancer Vaccines: Two sides. Same Coin
Linqi Zhang, Tsinghua University, China
Antibody profiling, epitope mapping and vaccine design based on yeast surface display system
Tongqing Zhou, Vaccine Research Center, NIAID/NIH, USA
From antibody to antibodyome: Seeking the coordinates for an effective HIV-1 vaccine
Jiang Zhu, NIH/NIAID, USA
Combining Deep Sequencing and Protein Design - A Systematic Approach to Vaccine Development
會議主題：
1. Immunology of vaccine
Focus on basic understanding how an effective vaccine may/should work including innate immunity, adjuvants, systems biological approaches to studying immune responses in humans etc.
2. Translating immunity to vaccine against leading diseases: HIV, malaria, TB, cancer and others
Focus on vaccine design, delivery, evaluation through various novel approach including systems biology.
3. Antibody and vaccine development
This session will focus more on some of the newer ideas and approaches to systemically characterize the initiation, evolution and maturation of immune responses in infected and vaccinated individuals. Novel ideas in vaccine design based on structure-function relationship between antibodyantigen should also been highlighted.
1. Immunology of vaccine
Focus on basic understanding how an effective vaccine may/should work including innate immunity, adjuvants, systems biological approaches to studying immune responses in humans etc.
2. Translating immunity to vaccine against leading diseases: HIV, malaria, TB, cancer and others
Focus on vaccine design, delivery, evaluation through various novel approach including systems biology.
3. Antibody and vaccine development
This session will focus more on some of the newer ideas and approaches to systemically characterize the initiation, evolution and maturation of immune responses in infected and vaccinated individuals. Novel ideas in vaccine design based on structure-function relationship between antibodyantigen should also been highlighted.
|
|
聯(lián)系方式： Cold Spring Harbor Asia No.299 Qiyue Road, SIP/ Suzhou, Jiangsu Province, China Tel: +86-512-62729029 Fax: +86-512-62729028 Email: mikeji@cshl.edu Website: www.csh-asia.org |
相關(guān)鏈接： 2013年冷泉港亞洲（CSH Asia）會議搶先預(yù)覽！
- 因美納邀您參加CSCO第九屆血液腫瘤學(xué)術(shù)大會
- 千奧星科精彩亮相2025神經(jīng)科學(xué)技術(shù)研討會
- 諾達思攜多款產(chǎn)品亮相2025中國人類工效學(xué)學(xué)術(shù)會議
- 美森與您相約CMC-CHINA第七屆中國制藥工業(yè)博覽會
- CPHI&PMEC 2025制藥工業(yè)展（深圳）通知
- 2026第三十三屆成都醫(yī)療健康博覽會邀請函
- NGDx2025中國先進診斷技術(shù)開發(fā)與應(yīng)用論壇議程表
- 關(guān)于征集藥食同源及藥膳配方食品標準試點單位的通知
- 關(guān)于征集藥食同源優(yōu)選產(chǎn)品評價規(guī)范參編單位的通知
- QD中國攜單細胞方案亮相國際干細胞研究學(xué)會年會
- 維拓啟創(chuàng)助力2025表面肌電論壇在杭成功召開
- 易科泰應(yīng)邀參加動物遺傳專業(yè)委員會2025年學(xué)術(shù)年會
- 奧偉登攜前沿顯微技術(shù)亮相廈門2025中國材料大會
- CIIDC 2025中國（成都）儀器創(chuàng)新發(fā)展大會通知
- 2025新疆（昌吉）農(nóng)業(yè)展覽會即將震撼啟幕
- 杭州費雪推出新品豬流行性腹瀉（PEDV）單克隆抗體
- Agrisera直播：從抗體選擇到WB全流程優(yōu)化策略
- MCE中國抗體實驗圖征稿啟示，秀美圖贏AirPods
- 斯達特生物將亮相2025年美國AACR展會，誠邀您蒞臨！
- MCE直播預(yù)告：銅死亡的機制探索與醫(yī)學(xué)應(yīng)用
- 2024第九屆疫苗中國領(lǐng)導(dǎo)者年會通知
- MCE推出超900種一抗和多種二抗產(chǎn)品，涵蓋熱門靶點
- 丹納赫將收購Abcam以推動生命科學(xué)領(lǐng)域研究創(chuàng)新進程
- 睿捷生物新學(xué)期新福利，四重優(yōu)惠限時享
- 佰諾全景科研mIHC病理技術(shù)服務(wù)年中大促銷火熱來襲
- 西美杰KPL熱銷二抗和底物限時優(yōu)惠活動已啟動！
- 美國Jackson二抗產(chǎn)品暑期促銷
- PhytoAB推出調(diào)節(jié)ABA受體PYLs相關(guān)蛋白抗體
- 菲恩生物推出抗體等試劑產(chǎn)品五一節(jié)三重禮促銷活動
- 2023疫苗創(chuàng)新國際論壇通知
Copyright(C) 1998-2025 生物器材網(wǎng) 電話：021-64166852;13621656896 E-mail：info@bio-equip.com